Global Information
회사소개 | 문의 | 위시리스트

미국의 양자선 치료 시장 : 환자수, 상환 정책, 양자선 치료 센터에서 치료중인 환자수

United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers

리서치사 Renub Research
발행일 2019년 08월 상품 코드 484586
페이지 정보 영문 147 Pages
가격
US $ 1,995 ₩ 2,423,000 Unprintable PDF by E-mail (Single User License)
US $ 2,495 ₩ 3,030,000 PDF by E-mail (5 User License)
US $ 2,495 ₩ 3,030,000 Unprintable PDF and Hard Copy
US $ 2,995 ₩ 3,637,000 PDF by E-mail (Global Site License)

주의 : 본 보고서는 PDF 파일 이용 시 라이선스에 따라 보고서 인쇄가 제한됩니다.
Single User License 구입 시에는 인쇄가 불가능하므로 이용에 주의하시기 바랍니다.



미국의 양자선 치료 시장 : 환자수, 상환 정책, 양자선 치료 센터에서 치료중인 환자수 United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers
발행일 : 2019년 08월 페이지 정보 : 영문 147 Pages

미국의 양자선 치료(Proton Therapy) 시장에 대해 조사 분석했으며, 현재 시장과 잠재 시장을 대상으로 환자수, 암 종류, 치료 센터 리스트, 경제성, 기업 분석 등에 대한 체계적인 정보를 제공합니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장(현재, 잠재) - 미국의 양자선 치료 시장

  • 양자선 치료 : 현재 시장
  • 양자선 치료 : 잠재 시장

제5장 환자수 - 미국의 양자선 치료

  • 실수
  • 잠재수

제6장 암 종류 - 미국의 양자선 치료 환자수

  • 중추신경계(CNS) 종양
  • 안구내 흑색종
  • 하수체 종양
  • 두개저/중축골격 종양
  • 두경부암
  • 폐암
  • 후복막육종
  • 소아암(18세 이하)
  • 소화관암
  • 요로암
  • 여성용 골반내 장기암
  • 전립선암
  • 유방암
  • 기타

제7장 암 종류 - 미국의 양자선 치료 시장

  • 중추신경계(CNS) 종양
  • 안구내 흑색종
  • 하수체 종양
  • 두개저/중축골격 종양
  • 두경부암
  • 폐암
  • 후복막육종
  • 소아암(18세 이하)
  • 소화관암
  • 요로암
  • 여성용 골반내 장기암
  • 전립선암
  • 유방암
  • 기타

제8장 미국 - 양자선 치료 센터 리스트

  • 가동중
  • 건설중
  • 계획중

제9장 센터별 - 치료중인 환자수

  • Loma Linda(LLUMC) Proton Therapy Center
  • UCSF - CNL Proton Therapy Center
  • Boston(NPTC) Proton Therapy Center
  • Bloomington(MPRI, 2) Proton Therapy Center
  • Houston(MD Anderson) Proton Therapy Center
  • UFPTI Jacksonville Proton Therapy Center
  • Oklahoma City(ProCure PTC) Proton Therapy Center
  • CDH Warrenville Proton Therapy Center
  • Philadelphia(Upenn) Proton Therapy Center
  • Hampton(HUPTI) Proton Therapy Center
  • New Jersey(ProCure PTC) Proton Therapy Center
  • Seattle(SCCA ProCure PTC) Proton Therapy Center
  • St. Louis(S. Lee King PTC) Proton Therapy Center
  • Provision Center for Proton Therapy, Knoxville, TN
  • San Diego(Scripps PTC)(2014 - 2017)
  • Shreveport(Willis Knighton) Proton Therapy Center
  • Jacksonville(Ackerman CC) Proton Therapy Center
  • Rochester(Mayo PBTC) Proton Therapy Center
  • Brunswick(Laurie PC) Proton Therapy Center
  • Irving(Texas Center for PT) Proton Therapy Center
  • Memphis(St. Jude PTC) Proton Therapy Center
  • Phoenix(Mayo PBTC) Proton Therapy Center
  • Baltimore(Maryland PTC) Proton Therapy Center
  • Cincinnati(Children's PTC) Proton Therapy Center
  • Orlando(Orlando Health PTC) Proton Therapy Center
  • Cleveland(UH Sideman PTC) Proton Therapy Center

제10장 양자선 치료 - 상환 정책

  • 환자용
  • 의료기관, 이해관계자, 제조업체용

제11장 표준적인 양자선 치료 센터의 구성요소

  • 양성자 가속기
  • 빔 수송 시스템
  • 빔 제공 시스템
  • 노즐
  • 치료 계획 시스템
  • 영상 뷰어
  • 환자 포지셔닝 시스템(PPS)
  • 인적 자원

제12장 기업 분석

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

제13장 성장 촉진요인

제14장 과제

KSM 19.08.07

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Figures:

  • Figure 2-1: United States - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: United States - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: United States - Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 - 2018
  • Figure 4-2: United States - Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2019 - 2025
  • Figure 4-3: United States - Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 - 2018
  • Figure 4-4: United States - Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2019 - 2025
  • Figure 4-5: United States - Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 - 2018
  • Figure 4-6: United States - Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2019 - 2025
  • Figure 4-7: United States - Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 - 2018
  • Figure 4-8: United States - Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2019 - 2025
  • Figure 4-9: United States - Proton Therapy Patient by Head and Neck Cancer (Number), 2009 - 2018
  • Figure 4-10: United States - Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2019 - 2025
  • Figure 4-11: United States - Proton Therapy Patient by Lung Cancer (Number), 2009 - 2018
  • Figure 4-12: United States - Forecast for Proton Therapy Patient by Lung Cancer (Number), 2019 - 2025
  • Figure 4-13: United States - Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 - 2018
  • Figure 4-14: United States - Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2019 - 2025
  • Figure 4-15: United States - Proton Therapy Patient by Pediatric Cancer (Number), 2009 - 2018
  • Figure 4-16: United States - Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2019 - 2025
  • Figure 4-17: United States - Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 - 2018
  • Figure 4-18: United States - Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2019 - 2025
  • Figure 4-19: United States - Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 - 2018
  • Figure 4-20: United States - Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2019 - 2025
  • Figure 4-21: United States - Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 - 2018
  • Figure 4-22: United States - Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2019 - 2025
  • Figure 4-23: United States - Proton Therapy Patient by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-24: United States - Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-25: United States - Proton Therapy Patient by Breast Cancer (Number), 2009 - 2017
  • Figure 4-26: United States - Forecast for Proton Therapy Patient by Breast Cancer (Number), 2019 - 2025
  • Figure 4-27: United States - Proton Therapy Patient by Other Cancer (Number), 2009 - 2018
  • Figure 4-28: United States - Forecast for Proton Therapy Patient by Other Cancer (Number), 2019 - 2025
  • Figure 5-1: United States - Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 - 2018
  • Figure 5-2: United States - Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2019 - 2025
  • Figure 5-3: United States - Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 - 2018
  • Figure 5-4: United States - Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2019 - 2025
  • Figure 5-5: United States - Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 - 2018
  • Figure 5-6: United States - Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2019 - 2025
  • Figure 5-7: United States - Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 - 2018
  • Figure 5-8: United States - Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2019 - 2025
  • Figure 5-9: United States - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-10: United States - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-11: United States - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-12: United States - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-13: United States - Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 - 2018
  • Figure 5-14: United States - Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2019 - 2025
  • Figure 5-15: United States - Proton Therapy Market by Pediatric Cancer (Million US$), 2009 - 2018
  • Figure 5-16: United States - Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2019 - 2025
  • Figure 5-17: United States - Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-18: United States - Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-19: United States - Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-20: United States - Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-21: United States - Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 - 2018
  • Figure 5-22: United States - Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2019 - 2025
  • Figure 5-23: United States - Proton Therapy Market by Prostate Cancer (Million US$), 2009 - 2018
  • Figure 5-24: United States - Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2019 - 2025
  • Figure 5-25: United States - Proton Therapy Market by Breast Cancer (Million US$), 2009 - 2018
  • Figure 5-26: United States - Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2019 - 2025
  • Figure 5-27: United States - Proton Therapy Market by Other Cancer (Million US$), 2009 - 2018
  • Figure 5-28: United States - Forecast for Proton Therapy Market by Other Cancer (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million US$), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue, (Million US$), 2019 - 2025
  • Figure 11-1: United States - Numbers of Patient Diagnosed With cancer (In Number), 2014 - 2018
  • Figure 11-2: United States - Forecast for Numbers of Patient Diagnosed With cancer (In Number), 2019 - 2025

United States is the hub of proton therapy industry where various advanced and children specialist centers and preferential facilities are available for the child. In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase. Proton therapy centers are growing at a rapid pace in United States as its cancer incidences are raising and there are more patients eligible for treatment than actually resources available for them. Proton therapy is one of the advanced techniques of radiotherapy which produces optimal amount of radiation or pinpoint radiation to kill tumor and mitigate radiation exposure to healthy tissues or cells. The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025. But the actual market is merely 10% of the potential market due to demand-supply mismatch.

Proton therapy is a non-invasive procedure that is used for the treatment of multiple cancers like CNS Cancer, Head & Neck Cancer, Prostate Cancer, Breast Cancer and Lung Cancer etc. People across the world are looking for the non-invasive procedure because of its effectiveness and painless outcome. The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

Besides, proton therapy can be an effective treatment for recurrent tumors. Proton therapy is one of the effective treatments for pediatric patients rather than conventional radiotherapy and surgery that include various risks and complications. Additionally, children body is prone to the re-occurrence of cancer and proton therapy plays an essential role by preventing from re-occurrence. The survival rate of proton therapy is nearly 90 percent which is far better than the traditional technique to treat cancer.

"United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" is a report published by Renub Research. In this report, we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about the list of all operational and Proton Therapy centers going to open in future; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

  • 1. Actual Market is the current market which is already present
  • 2. Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year

Patient Numbers for the Treatment of Proton Therapy in United States

In this report, we have portrayed proton therapy patients into two parts; potential patients and actual one. We have also categorized the proton therapy patient numbers on the basis of cancer type into 14 sections; Central Nervous System Tumors, Intraocular Melanomas, Pituitary Neoplasms, Base of Skull / Axial Skeleton, Head and Neck, Lung Cancers, Retroperitoneal Sarcoma, Pediatric (Up to Age 18), Gastrointestinal Tract, Urinary Tract, Female Pelvic Organs, Prostate Cancer, Breast Cancer and Other.

Proton Therapy Market for 14 Types of Cancer in United States

The proton therapy market is divided into two parts; potential proton therapy market and actual proton therapy market. This report studies the 14 cancer types proton therapy market Retroperitoneal Sarcoma, Central Nervous System Tumors, Pituitary Neoplasms, Intraocular Melanomas, Lung Cancers, Base of Skull / Axial Skeleton, Gastrointestinal Tract, Pediatric (Up to Age 18), Urinary Tract, Head and Neck, Breast Cancer, Female Pelvic Organs, Prostate Cancer, and Other.

According to Renub Research Analysis, the more patients of cancer would get proton therapy treatment in United States due to rising prevalence of cancer and an increasing number of the advanced proton therapy center. Additionally, increasing technological development in Proton therapy and increasing efficiencies will further boost the market of proton therapy in United States.

Number of Patients Treated in each Proton Therapy Center of United States

In this report, we have done a full assessment of proton therapy center of United States with their treatment capabilities and technology used. Currently, there are 31 operational centers for proton therapy in United States, and XX centers are in construction phase and XX are in planning phase. In this report we have provided complete patients number treated with proton therapy by each proton therapy center of United States.

Reimbursement Policy Insights

Here, we have done an in-depth analysis of reimbursement policies in United States. Here, we have fragmented the reimbursement policy into two parts; the first one is by patient's perspective, and the second one is by manufacturer, stakeholder and institutional perspective.

Key Companies Covered

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

United States Proton Therapy Market & Patient Numbers has been analyzed from two viewpoints

  • Actual & Potential Market
  • Actual & Potential Number of Patients Treated

14 Types of Cancer - Patient Numbers & Market

  • 1. Central Nervous System Tumors Cancer
  • 2. Pituitary Neoplasms Cancer
  • 3. Intraocular Melanomas Cancer
  • 4. Lung Cancers
  • 5. Base of Skull / Axial Skeleton Cancer
  • 6. Gastrointestinal Tract Cancer
  • 7. Pediatric (Up to Age 18) Cancer
  • 8. Urinary Tract Cancer
  • 9. Head and Neck Cancer
  • 10. Breast Cancer
  • 11. Female Pelvic Organs Cancer
  • 12. Prostate Cancer
  • 13. Retroperitoneal Sarcoma Cancer
  • 14. Other Cancer

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Potential Proton Therapy Market

5. Number of Patients - United States Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Potential Numbers

6. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2025)

  • 6.1. Central Nervous System Tumors
  • 6.2. Intraocular Melanomas Cancer
  • 6.3. Pituitary Neoplasms Cancer
  • 6.4. Base of Skull / Axial Skeleton Cancer
  • 6.5. Head and Neck Cancer
  • 6.6. Lung Cancer
  • 6.7. Retroperitoneal Sarcoma Cancer
  • 6.8. Pediatric Cancer Cases (Up to Age 18)
  • 6.9. Gastrointestinal Tract Cancer
  • 6.10. Urinary Tract Cancer
  • 6.11. By Female Pelvic Organs Cancer
  • 6.12. Prostate Cancer
  • 6.13. Breast Cancer
  • 6.14. Other Cancer

7. Cancer Types - United States Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System Tumors
  • 7.2. Intraocular Melanomas Cancer
  • 7.3. Pituitary Neoplasms Cancer
  • 7.4. Base of Skull / Axial Skeleton Cancer
  • 7.5. Head and Neck Cancer
  • 7.6. Lung Cancer
  • 7.7. Retroperitoneal Sarcoma Cancer
  • 7.8. Pediatric Cancer (Up to Age 18)
  • 7.9. Gastrointestinal Tract Cancer
  • 7.10. Urinary Tract Cancer
  • 7.11. Female Pelvic Organs Cancer
  • 7.12. Prostate Cancer
  • 7.13. Breast Cancer
  • 7.14. Other Cancer

8. United States - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers
  • 8.3. Planning Proton Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
  • 9.2. UCSF - CNL Proton Therapy Center (2008 - 2015)
  • 9.3. Boston (NPTC) Proton Therapy Center (2008 - 2016)
  • 9.4. Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
  • 9.5. Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
  • 9.6. UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
  • 9.7. Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
  • 9.8. CDH Warrenville Proton Therapy Center (2010 - 2016)
  • 9.9. Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
  • 9.10. Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
  • 9.11. New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
  • 9.12. Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
  • 9.13. St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
  • 9.14. Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
  • 9.15. San Diego (Scripps PTC) (2014 - 2017)
  • 9.16. Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
  • 9.17. Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
  • 9.18. Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
  • 9.19. Brunswick (Laurie PC) Proton Therapy Center (2015)
  • 9.20. Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
  • 9.21. Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
  • 9.22. Phoenix (Mayo PBTC) Proton Therapy Center (2016)
  • 9.23. Baltimore (Maryland PTC) Proton Therapy Center (2016)
  • 9.24. Cincinnati (Children's PTC) Proton Therapy Center (2016)
  • 9.25. Orlando (Orlando Health PTC) Proton Therapy Center (2016)
  • 9.26. Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

10. Proton Therapy - Reimbursement Policies

  • 10.1. Proton Therapy Reimbursement Policies for Patients
  • 10.2. Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

11. Components of a Standard Proton Therapy Center

  • 11.1. Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 10.2.2. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in United States

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operations Challenges
Back to Top
전화 문의
F A Q